Effects of a major gene for apolipoprotein A-I concentration are thyroid hormone dependent in Mexican Americans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 9, 1996, Pages 1177-1183

  Blangero, John ^a   Williams Blangero, Sarah ^a   Mahaney, Michael C ^a   Comuzzie, Anthony G ^a   Hixson, James E ^a   Samollow, Paul B ^a   Mark Sharp, R ^a   Stern, Michael P ^b   MacCluer, Jean W ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b Univ of Texas Health Science Center ^*  (United States)

Author keywords

apolipoprotein A I; genetics; linkage; lipoproteins; thyroid hormones

Indexed keywords

APOLIPOPROTEIN A1; LIOTHYRONINE; LIPOPROTEIN; MESSENGER RNA; THYROID HORMONE;

ADULT; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENETIC LINKAGE; GENOTYPE; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; STRUCTURAL GENE; THYROID HORMONE BLOOD LEVEL;

EID: 0029774799     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.9.1177     Document Type: Article

References (52)

1. Sing CF, Moll PP. Genetics of variability of CHD risk. hit J Epidemiol. 1989;18(suppl 1):S183-S195.
2. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
3. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 1987;113:433-440.
4. Wilson PF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272:1666-1671.
5. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM, for the EARS group. ApoE polymorphism and predisposition to coronary heart disease in youths of different populations: the EARS study. Arterioscler Thromb. 1994;14:1617-1624.
6. Humphries SE, Berg K, Gill L, Cumming AM, Robertson FW, Stalenhoef AF, Williamson R, Borresen AL. The gene for apolipoprotein (C-II) is closely linked to the gene for apolipoprotein E on chromosome 19. Clin Genet. 1984;26:389-396.
7. Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem. 1985;260:6240-6247.
8. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 1992;9:155-167.
9. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis, J Lipid Res. 1992;33:447-454.
10. Ukkola O, Kervinen K, Salmela PI, Von Dickhoff K, Laakso M, Kesäniemi YA. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 1993;101:9-15.
11. Murakami K, Shimizu M, Yamada N, Isnibashi S, Shimano H, Yazaki Y, Akanuma Y. Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM. Diabetes Care. 1993;16:564-569.
12. Eto M, Watanabe K, Iwashima Y, Morikawa A, Chonan N, Oshima E, Sekiguchi M, Ishii K. Increased frequency of apolipoprotein epsilon allele in type II diabetes with hypercholesterolemia. Diabetes. 1987;36:1301-1306.
13. Shen MM, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res, 1981;22:236-244.
14. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
15. Crouse JR, Parks JS, Schey HM, Kahl FR. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
16. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
17. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ. Low-density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
18. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R. Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527-1533.
19. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low-density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-490.
20. Swinkels DW, Demacker PNM, Hendriks JCM, van't Laar A. Lowdensity lipoprotein subfractions and relationship of other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis. 1989;9:604-613.
21. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:381-387.
22. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
23. Haffner SM, Mykkänen L, Valdez RA, Paidi M, Stern MP, Howard BV. LDL and subclass pattern in a biethnic population. Arterioscler Thromb. 1993;13:1623-1630.
24. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV, Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 1994;17:1164-1171.
25. Haffner SM, Mykkänen L, Paidi M, Valdez R, Howard BV, Stern MP. Small dense LDL is associated with the insulin resistance syndrome. Diabetologia. 1995;38:1328-1336.
26. Austin MA, King MC, Vranizan KM, Newman MC, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
27. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of lowdensity lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 1990;10:520-530.
28. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci U S A. 1992;89:708-712.
29. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF. Effect of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb. 1994;14:1105-1113.
30. Zhao SP, Verhoeven MH, Vink J, Hollaar L, Van der Laarse A, de Knijff P, van't Hooft FM. Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis. 1993;102:147-154.
31. Valdez R, Howard BV, Stern MP, Haffner SM. Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care. 1995;18:992-1000.
32. Després JP, Verdon MF, Moorjani S, Pouliot MC, Nadeau A, Bouchard C, Tremblay A, Lupien PJ. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes. 1993;42:1474-1481.
33. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol. 1984;120:834-851,
34. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220-224.
35. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler-CW, Rosenthal M. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol. 1986;123:96-112.
36. Bio-dynamics BMC Autoflo Cholesterol Method. Indianapolis, Ind: Bio-dynamics; 1977. Catalog No. 148393.
37. Abbott Laboratories Diagnostic Division. ABA-100/A-Gent Systems: Triglyceride. South Pasadena, Calif: Abbott Laboratories:1976.
38. Lipid Research Clinics Program. Manual of Laboratory Operations, Vol 1: Lipid and Lipoprotein Analyses. Washington, DC: US Government Printing Office; 1975. US Dept of Health, Education, and Welfare publication NIH 75-628.
39. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
40. World Health Organization. WHO Expert Committee on Diabetes Mellitus, Second Report Geneva. World Health Organization; 1980. Technical Report Series No. 646.
41. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Do upper body and centralized adiposity measure different aspects of regional body fat distribution?: relationship to non-insulin-dependent diabetes mellitus, lipids and lipoproteins. Diabetes. 1987;36:43-51.
42. Kataoka S, Paidi M, Howard BV. Simplified isoelectric focusing/ immunoblotting determination of apoprotein E phenotype. Clin Chem. 1994;40:11-13.
43. SAS Institute. SAS/STAT User's Guide, Version 6.11. 4th ed. Cary, NC: SAS Institute;.
44. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz A, Galteau MM, Visuikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem. 1995;41:1068-1086.
45. Hixson JE and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 1991;15:1237-1244.
46. Demant T, Bedford D, Packard CJ, Sheperd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipidemic subjects. J Clin Invest. 1991;88:1490-1501.
47. Miettinen TA, Gylling H, Vanhanen H, Ollus A, Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes, Arterioscler Thromb. 1992;12:1044-1052.
48. Brenninkmeijer BJ, Stuyt PMJ, Demacker PNM, Stalenhoef AFH, van't Laar A. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res. 1987;28:361-370.
49. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest. 1987;80:1571-1577.
50. Demant T, Bedford D, Packard CJ, Shepherd J. Apolipoprotein E polymorphism and apolipoprotein B metabolism in vivo. Circulation. 1989;80(suppl II):II-277. Abstract.
51. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest. 1987;80:578-581.
52. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res. 1992;33:1361-1371.